atropine: be contraindicated in myasthenia gravis

Property	Similarity
be contraindicated in myasthenia gravis	1.00
be contraindicated in hypertrophy	0.93
be contraindicated in heart block	0.93
be contraindicated in prostatic hypertrophy	0.91
be contraindicated in hypothermia	0.90
be contraindicated in heart transplant patients	0.88
be used for bradycardia	0.78
be given for bradycardia	0.77
is administered preoperatively	0.75

0.74

Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.93

Evidence: 0.91

Typical(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.72

¬ Typical(atropine, be contraindicated in hypertrophy)

0.73

Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.91

Evidence: 0.91

Typical(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.59

¬ Typical(atropine, be contraindicated in prostatic hypertrophy)

0.72

Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.93

Evidence: 0.91

Typical(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.92

¬ Typical(atropine, be contraindicated in heart block)

0.70

Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.90

Evidence: 0.91

Typical(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.85

¬ Typical(atropine, be contraindicated in hypothermia)

0.69

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.93

Evidence: 0.85

Salient(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.83

¬ Salient(atropine, be contraindicated in hypertrophy)

0.69

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.93

Evidence: 0.83

Plausible(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.72

¬ Plausible(atropine, be contraindicated in hypertrophy)

0.69

Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.91

Evidence: 0.83

Plausible(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.63

¬ Plausible(atropine, be contraindicated in prostatic hypertrophy)

0.69

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.93

Evidence: 0.85

Salient(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.90

¬ Salient(atropine, be contraindicated in heart block)

0.69

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.91

Evidence: 0.85

Salient(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.79

¬ Salient(atropine, be contraindicated in prostatic hypertrophy)

0.68

Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.90

Evidence: 0.85

Salient(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.74

¬ Salient(atropine, be contraindicated in hypothermia)

0.68

Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.88

Evidence: 0.91

Typical(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.97

¬ Typical(atropine, be contraindicated in heart transplant patients)

0.67

Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.93

Evidence: 0.83

Plausible(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.86

¬ Plausible(atropine, be contraindicated in heart block)

0.67

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.90

Evidence: 0.83

Plausible(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.74

¬ Plausible(atropine, be contraindicated in hypothermia)

0.65

Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.88

Evidence: 0.85

Salient(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.94

¬ Salient(atropine, be contraindicated in heart transplant patients)

0.63

Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.88

Evidence: 0.83

Plausible(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.91

¬ Plausible(atropine, be contraindicated in heart transplant patients)

0.63

Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.78

Evidence: 0.91

Typical(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.59

¬ Typical(atropine, be used for bradycardia)

0.63

Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.77

Evidence: 0.85

Salient(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.31

¬ Salient(atropine, be given for bradycardia)

0.63

Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.78

Evidence: 0.85

Salient(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.40

¬ Salient(atropine, be used for bradycardia)

0.62

Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.77

Evidence: 0.91

Typical(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.65

¬ Typical(atropine, be given for bradycardia)

0.61

Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.78

Evidence: 0.83

Plausible(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.47

¬ Plausible(atropine, be used for bradycardia)

0.61

Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.77

Evidence: 0.83

Plausible(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.43

¬ Plausible(atropine, be given for bradycardia)

0.61

Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.75

Evidence: 0.91

Typical(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.52

¬ Typical(atropine, is administered preoperatively)

0.60

Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.75

Evidence: 0.85

Salient(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.42

¬ Salient(atropine, is administered preoperatively)

0.60

Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.90

Evidence: 0.49

Remarkable(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.43

¬ Remarkable(atropine, be contraindicated in hypothermia)

0.59

Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.75

Evidence: 0.83

Plausible(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.45

¬ Plausible(atropine, is administered preoperatively)

0.58

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.77

Evidence: 0.49

Remarkable(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.24

¬ Remarkable(atropine, be given for bradycardia)

0.57

Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.93

Evidence: 0.49

Remarkable(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.54

¬ Remarkable(atropine, be contraindicated in heart block)

0.57

Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.88

Evidence: 0.49

Remarkable(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.47

¬ Remarkable(atropine, be contraindicated in heart transplant patients)

0.54

Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.78

Evidence: 0.49

Remarkable(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.38

¬ Remarkable(atropine, be used for bradycardia)

0.50

Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.93

Evidence: 0.49

Remarkable(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.72

¬ Remarkable(atropine, be contraindicated in hypertrophy)

0.49

Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.75

Evidence: 0.49

Remarkable(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.45

¬ Remarkable(atropine, is administered preoperatively)

0.46

Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.91

Evidence: 0.49

Remarkable(atropine, be contraindicated in myasthenia gravis) ⋁

Evidence: 0.78

¬ Remarkable(atropine, be contraindicated in prostatic hypertrophy)

Parents	drug Weight: 0.66 , alkaloid Weight: 0.59 , agent Weight: 0.57 , substance Weight: 0.55 , medicine Weight: 0.51
Siblings	phenobarbital Weight: 0.36 , acetaminophen Weight: 0.36 , ibuprofen Weight: 0.35 , morphine Weight: 0.35 , metronidazole Weight: 0.35

atropine: be contraindicated in myasthenia gravis

Related concepts

Related properties

Priors about this statement

Cues

Evidence

Clauses

Salient implies Plausible

Similarity expansion

Typical and Remarkable implies Salient

Typical implies Plausible